Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
STMicroelectronics
STM
$23.3B
| $485K | ﹤0.01% |
+11,215
| New | +$485K |
|
2877
Choiceone Financial
COFS
$456M
| $484K | ﹤0.01% |
17,700
+1,000
| +6% | +$27.3K |
|
2878
RAVE Restaurant Group
RAVE
$47.3M
| $484K | ﹤0.01% |
221,022
+16,900
| +8% | +$37K |
|
2879
Equillium
EQ
$118M
| $483K | ﹤0.01% |
209,200
-138,300
| -40% | -$319K |
|
2880
Nabors Industries
NBR
$619M
| $482K | ﹤0.01% |
5,600
-45,800
| -89% | -$3.94M |
|
2881
Lakeland Financial Corp
LKFN
$1.68B
| $481K | ﹤0.01% |
+7,251
| New | +$481K |
|
|
SGMA
2882
DELISTED
Sigmatron International
SGMA
| $479K | ﹤0.01% |
132,087
+2,000
| +2% | +$7.25K |
|
2883
Innoviz Technologies
INVZ
$371M
| $478K | ﹤0.01% |
+353,754
| New | +$478K |
|
2884
Ovid Therapeutics
OVID
$88.9M
| $478K | ﹤0.01% |
156,800
+105,600
| +206% | +$322K |
|
2885
Oportun Financial
OPRT
$283M
| $475K | ﹤0.01% |
195,585
+21,085
| +12% | +$51.2K |
|
2886
NCR Atleos
NATL
$2.85B
| $474K | ﹤0.01% |
+24,000
| New | +$474K |
|
|
CTHR
2887
DELISTED
Charles & Colvard Ltd
CTHR
| $473K | ﹤0.01% |
138,637
-3,720
| -3% | -$12.7K |
|
2888
argenx
ARGX
$46.7B
| $472K | ﹤0.01% |
+1,200
| New | +$472K |
|
|
IRS
2889
IRSA Inversiones y Representaciones
IRS
$991M
| $472K | ﹤0.01% |
52,242
+3,810
| +8% | +$34.4K |
|
2890
Vanguard Mid-Cap Growth ETF
VOT
$17.9B
| $472K | ﹤0.01% |
+2,000
| New | +$472K |
|
2891
Solitario Resources
XPL
$69.5M
| $469K | ﹤0.01% |
782,018
+51,846
| +7% | +$31.1K |
|
2892
Better Online Solutions
BOSC
$30.2M
| $467K | ﹤0.01% |
153,116
-2,195
| -1% | -$6.7K |
|
|
FINV
2893
FinVolution Group
FINV
$1.94B
| $464K | ﹤0.01% |
92,100
-1,800
| -2% | -$9.07K |
|
|
IGMS
2894
DELISTED
IGM Biosciences
IGMS
| $464K | ﹤0.01% |
48,100
+11,500
| +31% | +$111K |
|
|
TSRI
2895
DELISTED
TSR Inc. New
TSRI
| $463K | ﹤0.01% |
58,650
-1,726
| -3% | -$13.6K |
|
2896
Hamilton Beach Brands
HBB
$193M
| $463K | ﹤0.01% |
19,000
-8,692
| -31% | -$212K |
|
|
CGC
2897
Canopy Growth
CGC
$434M
| $461K | ﹤0.01% |
53,469
-25,839
| -33% | -$223K |
|
|
VTRU
2898
DELISTED
Vitru Limited Common Shares
VTRU
| $461K | ﹤0.01% |
30,610
-400
| -1% | -$6.02K |
|
2899
Cardiff Oncology
CRDF
$138M
| $460K | ﹤0.01% |
86,100
-30,300
| -26% | -$162K |
|
2900
Minerva Neurosciences
NERV
$15M
| $459K | ﹤0.01% |
177,765
+70,565
| +66% | +$182K |
|